Synthesis of fluorene and/or benzophenone O-oxime ethers containing amino acid residues and study of their cardiovascular and antibacterial effects-Reference-Cited by-同舟云学术

Synthesis of fluorene and/or benzophenone O-oxime ethers containing amino acid residues and study of their cardiovascular and antibacterial effects

Published:2014-03-02 Issue:8 Volume:23 Page:3810-3822
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Soltani Rad Mohammad Navid,Behrouz Somayeh,Zarenezhad Elham,Moslemin Mohammad Hossein,Zarenezhad Ali,Mardkhoshnood Mehdi,Behrouz Marzieh,Rostami Saeid

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/s00044-014-0967-3.pdf

Reference37 articles.

1. Balsamo A, Breschi MC, Chiellini G, Favero L, Macchia M, Martinelli A, Martini C, Rossello A, Scatizzi R (1995) Synthesis and β-adrenergic properties of (E)-N-[3-(alkylamino)-2-hydroxypropylidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM β-blocking drugs. Eur J Med Chem 30:743–755. doi: 10.1016/0223-5234(96)88293-6

2. Balsamo A, Breschi MC, Chiellini G, Macchia B, Macchia M, Manera C, Saccà P, Scatizzi R (1996) New chiral methyloxyiminomethyl (MOIM) β-adrenergic antagonists. (S)- and (R)-N-[3-(alkylamino)-2-hydroxypropylidene](p-chlorophenylmethyloxy)amines as probes for determining enantiomeric specificity in the class of MOIM-type β-adrenergic blocking agents. Eur J Med Chem 31:199–206. doi: 10.1016/0223-5234(96)89135-5

3. Balsamo A, Breschi MC, Chiellini G, Lapucci A, Lazzeri N, Macchia M, Martinelli A, Micali E, Nencetti S, Rossello A (1998) Synthesis and beta-adrenergic properties of (Z)-N-[3-(alkylamino)-2-hydroxypropylidene](aryl-methyloxy)amines: effects of the configuration around the methyloxyiminomethyl (MOIM) double bond on the biopharmacological properties of MOIM-type beta-blocking agents. Bioorg Med Chem 6:2151–2160. doi: 10.1016/S0968-0896(98)00172-2

4. Balsamo A, Macchia M, Martinelli A, Rossello A (1999) The [(methyloxy)imino]methyl moiety (MOIMM) in the design of a new type of β-adrenergic blocking agent. Eur J Med Chem 34:283–291. doi: 10.1016/S0223-5234(99)80079-8

5. Breschi MC, Macchia M, Manera C, Micali E, Nardini C, Nencetti S, Rossello A, Scatizzi R (1996) Conformationally restrained β-blocking oxime ethers. 3. Synthesis and β-adrenergic antagonistic activity of diastereomeric anti and syn 2-(5′-(3′-methyl)isoxazolidinyl)-N-alkylethanolamines. Eur J Med Chem 31:159–163. doi: 10.1016/0223-5234(96)80449-1

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, cytotoxic evaluation, molecular docking studies and molecular dynamic simulation of some metronidazole analogues;Journal of Molecular Structure;2023-07

2. A Review of Biologically Active Oxime Ethers;Molecules;2023-06-28

3. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors;International Journal of Biological Macromolecules;2023-06

4. Synthesis, Biological Evaluation and In Silico Studies of Oxime Ether Derivatives Containing a Quinoxaline Moiety;Russian Journal of Bioorganic Chemistry;2022-12-22

5. New Thiazole Acetic Acid Derivatives: A Study to Screen Cardiovascular Activity Using Isolated Rat Hearts and Blood Vessels;Molecules;2022-09-20